Vapotherm Inc
F:VA21
Relative Value
There is not enough data to reliably calculate the relative value of VA21.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
VA21 Competitors Multiples
Vapotherm Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
V
|
Vapotherm Inc
F:VA21
|
137.6m EUR | 2.4 | -2.8 | -7.9 | -6.9 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
195.4B USD | 4.4 | 30 | 17 | 23.2 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
178.4B USD | 17.7 | 62.3 | 47.5 | 57.5 | |
| US |
|
Stryker Corp
NYSE:SYK
|
136.7B USD | 5.6 | 43.5 | 22 | 26.7 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
130.1B USD | 3.8 | 27.7 | 15.5 | 22.4 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
109.9B USD | 5.7 | 39.7 | 23.6 | 32.1 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
47.7B USD | 2.2 | 29.2 | 11.2 | 19 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
46.4B EUR | 2 | 21.8 | 12 | 17 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
51.2B USD | 12 | 48.9 | 35 | 38.6 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
44.6B USD | 7.7 | 33 | 23.4 | 25.7 | |
| US |
|
Resmed Inc
NYSE:RMD
|
39.9B USD | 7.4 | 27 | 19.1 | 21.2 |